Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Schedule a COVID vaccine appointment

Schedule a COVID vaccine appointment: call us 8am to 5pm, Monday through Friday, at 267-758-4902.

Vivianna M. Van Deerlin, MD, PhD

Vivianna M. Van Deerlin, MD, PhD
No patient ratings. Why not?
Why doesn't this doctor have a rating?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Sees Adults (18-65), Geriatrics (65+)

Vivianna M. Van Deerlin, MD, PhD

No patient ratings. Why not?
Why doesn't this doctor have a rating?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Sees Adults (18-65), Geriatrics (65+)

  • Director, Molecular Pathology Laboratory
  • Director, Saliva COVID Testing Lab, Hospital of the University of Pennsylvania
  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
  • Dr. Van Deerlin is a Penn Medicine physician.

Meet Dr. Van Deerlin

My clinical expertise is in Molecular Pathology. The clinical laboratory I direct is a full service CLIA certified molecular pathology laboratory that encompasses testing in all areas including oncology (hematological and solid tumor), infectious diseases, genetics, hereditary and somatic pharmacogenetics, and identity testing. Currently we have a major emphasis on the development of oncology-based tests including somatic pharmacogenetics. Somatic pharmacogenetics represents somatic changes in tumors that make them more or less susceptible to therapeutic approaches. With the development of new targeted therapies, this type of molecular oncology testing is ever more critical for clinical management of patients. Other areas of growth include molecular infectious disease testing.

Back To Top